Abstract: A process for preparing a mixture of cetyl myristate and cetyl palmitate comprising reacting both myristic and palmitic acid with cetyl alcohol with an acid catalyst and one aromatic hydrocarbon at an elevated temperature and recovering from the aromatic hydrocarbon fraction the cetyl myristate and cetyl palmitate.
Abstract: A treatment for humans or other mammals for irritable bowel syndrome (IBS) or irritable bowel disease (IBD) is disclosed using dosage forms or compositions that comprise cetyl myristate alone or (in admixture or serially) both cetyl myristate and cetyl palmitate.
Type:
Grant
Filed:
March 27, 2003
Date of Patent:
February 24, 2004
Assignee:
Meracol Corporation Limited
Inventors:
Timothy David Meakin, Dianne Cadwallader, Craig Leonard Heatley